Forty-five years of Duchenne muscular dystrophy in The Netherlands

Autor: Jan J.G.M. Verschuuren, B.H.A. Wokke, M. E. Van Der Tol, I.J.M. de Groot, Peter J. Wijkstra, Chiara S. M. Straathof, Erik H. Niks, Marianne Zijnen, M.E.B. Rijlaarsdam, Nicole A. M. Cobben, J.C. van den Bergen, A. M. C. Horemans, Johanna M. Fock, Elizabeth Vroom, H.B. Ginjaar, I.F.M. de Coo, R.F. Pangalila, A. J. van Essen, Mike J. Kampelmacher

Publikováno v: Journal of Neuromuscular Diseases, 1(1), 99-109
Journal of Neuromuscular Diseases, 1, pp. 99-109
Journal of Neuromuscular Diseases, 1, 99-109

Background: Duchenne muscular dystrophy (DMD) is a progressive muscle disease. No curative therapy is currently available, but in recent decades standards of care have improved. These improvements include the use of corticosteroids and mechanical ven

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::331d1e969a62b10a76a13b94c09ab98a
https://research.rug.nl/en/publications/c217de5d-ae4e-480d-8672-e40a58ac5751

A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood

Autor: C J, de Haas, M E, van der Tol, K P, Van Kessel, J, Verhoef, J A, Van Strijp

Publikováno v: Journal of immunology (Baltimore, Md. : 1950). 161(7)

LPS-binding proteins in plasma play an important role in modifying LPS toxicity. Significant properties have already been attributed to the LPS-binding protein (LBP). It accelerates LPS toxicity as well as incorporation into high-density lipoproteins

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::119c30482c8351fc7cdc34f54bce5904
https://pubmed.ncbi.nlm.nih.gov/9759883

Modulation of lipopolysaccharide binding to human granulocytes

Autor: A J, Weersink, K P, Van Kessel, M E, Van der Tol, J, Verhoef

Publikováno v: Immunology. 83(4)

Using flow cytometry and fluorescein-labelled lipopolysaccharide (LPS) from Salmonella minnesota R595 (FITC-ReLPS), we studied the role of membrane proteins in the recognition of LPS by human polymorphonuclear granulocytes (PMN) in the absence of ser

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c1415369a05dc49ee2bc40653c4d5566
https://pubmed.ncbi.nlm.nih.gov/7533136

Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization

Autor: W C Van Dijk, R. Peters, Jan Verhoef, H. A. Verbrugh, M E van der Tol

Publikováno v: Infection and Immunity. 25:603-609

Escherichia coli strains with K capsular polysaccharides are relatively resistant to phagocytosis by polymorphonuclear leukocytes, in contrast to E. coli strains without K antigens. This inhibition of phagocytosis is related to an impaired recognitio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7d30dbe0e452117dd6a88825e4b7349
https://doi.org/10.1128/iai.25.2.603-609.1979

Quantitation of Conjugate Formation Between Human Polymorphonuclear Leukocytes and Antibody-Coated Target Cells by Flow Cytometry: The Role of Fc Receptor and LFA-1 Antigen

Autor: K. P. M. Van Kessel, R. M. W. M. Thijssen, M. E. Van Der Tol, Jan Verhoef, H. J. Van Kats-Renaud, Ad C. Fluit, J. A. G. Van Strijp

Publikováno v: Journal of Leukocyte Biology. 46:467-475

The specific binding of human polymorphonuclear leukocytes (PMN) to antibody-coated target cells was characterized by flow cytometry. PMN were labeled with phycoerythrin-E (PE) via a granulocyte-specific monoclonal antibody (leu-M1) and mixed with fl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71045b25668412fcee51a939f41003e4
https://doi.org/10.1002/jlb.46.5.467